QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$42.10 USD
-1.87 (-4.25%)
Updated Feb 6, 2025 04:00 PM ET
After-Market: $42.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Income Statements
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | |
---|---|---|---|---|---|
Sales | NA | 2,998 | 3,266 | 1,699 | 1,662 |
Cost Of Goods | NA | 1,503 | 1,330 | 428 | 313 |
Gross Profit | NA | 1,494 | 1,936 | 1,271 | 1,349 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 1,355 | 1,092 | 365 | 289 |
Income After Depreciation & Amortization | 0 | 139 | 844 | 906 | 1,060 |
Non-Operating Income | NA | -21 | -32 | 0 | -10 |
Interest Expense | NA | 148 | 76 | 6 | 10 |
Pretax Income | NA | -29 | 736 | 900 | 1,040 |
Income Taxes | NA | -19 | 187 | 196 | 230 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -10 | 549 | 704 | 810 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -10 | 549 | 704 | 810 |
Depreciation Footnote | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 596 | 1,117 | 965 | 1,117 |
Depreciation & Amortization (Cash Flow) | NA | 457 | 273 | 59 | 56 |
Income After Depreciation & Amortization | 0 | 139 | 844 | 906 | 1,060 |
Earnings Per Share Data | 12/31/24 | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 66.80 | 57.40 | 42.87 | 43.59 |
Diluted EPS Before Non-Recurring Items | NA | 4.13 | 13.76 | 17.27 | 19.55 |
Diluted Net EPS (GAAP) | NA | -0.15 | 9.56 | 16.43 | 18.60 |
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/24 | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | |
---|---|---|---|---|---|
Sales | NA | 727.10 | 637.00 | 711.00 | 742.60 |
Cost Of Goods | NA | 374.80 | 361.00 | 378.90 | 361.30 |
Gross Profit | NA | 352.30 | 276.00 | 332.10 | 381.30 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 337.30 | 393.50 | 2,090.10 | 341.20 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 15.00 | -117.50 | -1,758.00 | 40.10 |
Non-Operating Income | NA | -0.90 | -4.40 | -1.90 | -12.60 |
Interest Expense | NA | 42.90 | 41.00 | 39.00 | 36.70 |
Pretax Income | NA | -28.80 | -162.90 | -1,798.90 | -9.20 |
Income Taxes | NA | -8.90 | -15.20 | -92.90 | -16.20 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -19.90 | -147.70 | -1,706.00 | 7.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -19.90 | -147.70 | -1,706.00 | 7.00 |
Earnings Per Share Data | 12/31/24 | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 67.30 | 67.10 | 66.90 | 67.30 |
Diluted EPS Before Non-Recurring Items | NA | 0.85 | -0.07 | 0.36 | 1.17 |
Diluted Net EPS (GAAP) | NA | -0.30 | -2.20 | -25.50 | 0.11 |